Evidence map›Paper›PMID 27197517›Full record

ArticleInfectious diseases of poverty2016

Shrinking the malaria map in China: measuring the progress of the National Malaria Elimination Programme.

Tao Hu, Yao-Bao Liu, Shao-Sen Zhang, Zhi-Gui Xia, Shui-Sen Zhou, Jun Yan, Jun Cao, Zhan-Chun Feng

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Polymorphism of Drug Resistance GenesTropical medicine and infectious disease · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Opportunities for Subnational Malaria Elimination in High-Burden Countries.The American journal of tropical medicine and hygiene · 2020
    Article
  13. Article
  14. Article
  15. Protecting the gains of malaria elimination in China.Infectious diseases of poverty · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Tao HuSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.
Yao-Bao LiuJiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, People's Republic of China.
Shao-Sen ZhangNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Zhi-Gui XiaNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Shui-Sen ZhouNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, People's Republic of China.
Jun YanBureau of Disease Prevention and Control, National Health and Family Planning Commission of the People's Republic of China, Beijing, People's Republic of China.
Jun CaoJiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, People's Republic of China.
Zhan-Chun FengSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China. zcfeng@hust.edu.cn.
National Institute for Parasitic Diseases · CNNational Health and Family Planning Commission · CNHuazhong University of Science and Technology · CNJiangnan University · CNJiangsu Institute of Parasitic Diseases · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRemarkable progress has been made towards the elimination of malaria in China since the National Malaria Elimination Programme (NMEP) was launched in 2010. The incidence of locally-acquired malaria cases has declined rapidly and endemic areas have also dramatically shrunk. In total, 3 078 malaria cases were reported in 2014, but only 56 cases were indigenous. In order to further promote the elimination programme, we reviewed the progress of and experiences associated with malaria elimination in China, and identified the challenges and priorities for the next stage of the programme.

methodsData were collected from the web-based China Information System for Disease Control and Prevention, and the China Annual Report of Malaria Elimination. The progress towards the elimination of malaria from 2010 to 2014 was measured.

resultsDuring the implementation of the NMEP from 2010 to 2014, local malaria incidence has declined continuously, only remaining in the Yunnan Province and Tibet Autonomous Region in 2014. By the end of 2015, 75.6 % (1 636/2 163) of the malaria-endemic counties passed the sub-national elimination assessment. The main challenges are cases of border malaria and imported malaria from other countries. Sustainable support and investment from the government, the establishment of an effective surveillance and response system, and risk assessments for the potential reintroduction of malaria are priorities for the next stage of the elimination programme.

conclusionsThe NMEP in China has been successfully implemented thus far and the malaria map has shrunk dramatically. The priorities for malaria elimination are interventions to block transmission at border areas, management of imported malaria cases, preventing malaria reintroduction, capacity building, and sustainability of malaria surveillance and response.

Indexed as

ChinaEpidemiological MonitoringHumansIncidenceMalariaNational Health ProgramsPopulation SurveillanceRisk AssessmentTibetChallengesChinaExperiencesIncidenceMalaria eliminationProgress

Identifiers

PMID27197517
PMCPMC4873993
OpenAlexW2408655726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.